Comparable actions of omalizumab on mast cells and basophils-Reference-Cited by-同舟云学术

Comparable actions of omalizumab on mast cells and basophils

Published:2015-12-23 Issue:1 Volume:46 Page:92-102
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Serrano-Candelas E.¹²,Martinez-Aranguren R.³,Valero A.²⁴⁵,Bartra J.²⁴⁵,Gastaminza G.³,Goikoetxea M. J.³,Martín M.¹²,Ferrer M.³

Affiliation:

1. Biochemistry Unit; Faculty of Medicine; University of Barcelona; Barcelona Spain

2. Laboratory of Clinical and Experimental Respiratory Immunoallergy; IDIBAPS; Barcelona Spain

3. Department of Allergy and Clinical Immunology; Clinica Universidad de Navarra; Instituto de Investigación Sanitaria de Navarra (IDISNA); Pamplona Spain

4. Department of Pneumology and Allergy; Immunoallèrgia Respiratòria Clínica I Experimental; IDIBAPS; Hospital Clínic; Barcelona Spain

5. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES); Barcelona Spain

Funder

Novartis Spain

Health Research Fund

Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias, Ministerio de Economía y Competitividad)

Carlos III Health Institute of Spain

Spanish Research Network on Adverse Reactions to Allergens and Drugs (RIRAAF: Red de Investigación de Reacciones Adversas Alérgenos y Fármacos) of the Carlos III Health Institute

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12668/fullpdf

Reference43 articles.

1. Humanization of an antibody directed against IgE;Presta;J Immunol,1993

2. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab;Zheng;Biochem Biophys Res Commun,2008

3. Anti-IgE-emerging opportunities for Omalizumab;Babu;Expert Opin Biol Ther,2013

4. Omalizumab, an anti-immunoglobulin E antibody: state of the art;Incorvaia;Drug Drug Des Devel Ther,2014

5. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function;Beck;J Allergy Clin Immunol,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Immunological Biomarkers in Chronic Spontaneous Urticaria Patients Receiving Omalizumab Treatment;2024-07-22

2. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps;Frontiers in Immunology;2024-04-16

3. Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study;International Archives of Allergy and Immunology;2024

4. Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis;Journal of Personalized Medicine;2023-12-19

5. Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD;World Allergy Organization Journal;2023-09